Kepos Capital LP - TRANSCODE THERAPEUTICS INC ownership

TRANSCODE THERAPEUTICS INC's ticker is RNAZ and the CUSIP is 89357L105. A total of 18 filers reported holding TRANSCODE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Kepos Capital LP ownership history of TRANSCODE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$792,000
+3.9%
275,000
-8.3%
0.06%
-7.8%
Q4 2021$762,000
-15.1%
300,0000.0%0.06%
+6.7%
Q3 2021$897,000300,0000.06%
Other shareholders
TRANSCODE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,289,000$1,418,0000.44%
Worth Venture Partners, LLC 324,157$357,0000.22%
Redmond Asset Management, LLC 90,874$100,0000.04%
ACT CAPITAL MANAGEMENT, LLC 6,500$7,0000.01%
K.J. Harrison & Partners Inc 19,987$22,0000.01%
Shay Capital LLC 15,060$17,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 76,549$84,0000.00%
STATE STREET CORP 21,019$23,0000.00%
BlackRock Inc. 15,334$17,0000.00%
View complete list of TRANSCODE THERAPEUTICS INC shareholders